“Grail is taking on one of the biggest challenges of our lifetime, combining science, technology, and clinical studies to reveal cancer at its beginnings. To detect cancer early, when it can be cured. To uncover where it all begins, far before we have to worry about how it will end.
“Diagnosing cancer early results in significantly higher survival rates compared to late-stage diagnosis. However, effective screening only exists for a few cancer types, and most cancer is detected in later stages, when survival rates are much lower.
“In order to enable the most accurate detection of early stage cancer, GRAIL is conducting one of the largest clinical study programs ever pursued in genomic medicine. GRAIL is collaborating with leading community and academic medical centers to conduct studies enrolling tens of thousands of people to identify the patterns required to detect many types of cancer, and studies enrolling hundreds of thousands of people to confirm the clinical validity and utility of GRAIL’s products.”
Designed by Character